A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Losartan Impurity 25 | CAS 73963-29-8 - Request Quote

Picture of Losartan Impurity 25

Losartan Impurity 25

SZ CAT No:SZ-L028062
CAS No
73963-29-8
Mol.F.
C10H17ClN4
Mol.Wt.
228.7
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Losartan Impurity 25 is chemically 5-(3-Chloropropyl)-1-cyclohexyl-1H-tetrazole. Losartan Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Losartan Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Losartan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 73963-29-8

Purchase 73963-29-8

Order 73963-29-8

Enquire 73963-29-8

price of 73963-29-8

73963-29-8 Supplier

73963-29-8 Manufacturer

73963-29-8 Exporter

buy high quality Losartan Impurity 25

Purchase Losartan Impurity 25

Losartan Impurity 25 suppliers

Losartan Impurity 25 manufacturers

Losartan Impurity 25 price

Order Losartan Impurity 25

Enquire Losartan Impurity 25

Losartan Impurity 25 cost

Losartan Impurity 25 Supplier

Losartan Impurity 25 Distributor

Losartan Impurity 25 for Method Validation

Losartan Reference Standard

Losartan Impurity 25 for ANDA Filing

Losartan Impurity 25 for Forced Degradation Studies

Losartan Impurity 25 Identification Standards

Losartan Impurity 25 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,